ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 761

$385K Total Retail Price of All Prescriptions

Rank: 229 out of 761

755 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 6,794 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 338 282 1 4
SIMVASTATIN 332 299 2 2
LEVOTHYROXINE SODIUM 269 252 3 3
LISINOPRIL 241 227 4 1
AMLODIPINE BESYLATE 204 194 5 6
METFORMIN HCL 197 178 6 10
FUROSEMIDE 184 166 7 7
HYDROCODONE-ACETAMINOPHEN 176 144 S3 8 5
LOVASTATIN 171 158 9 17
GABAPENTIN 162 135 10 15
WARFARIN SODIUM 152 143 11 9
POTASSIUM CHLORIDE 140 132 12 18
CITALOPRAM HBR 112 99 13 19
FLUOXETINE HCL 110 94 14 31
HYDROCHLOROTHIAZIDE 92 85 15 11
LOSARTAN POTASSIUM 87 75 16 13
PRAVASTATIN SODIUM 85 71 17 20
BENAZEPRIL HCL 81 77 18 112
TRAMADOL HCL 81 77 18 34
CARVEDILOL 79 76 20 26
FLUTICASONE PROPIONATE 79 77 20 29
ATENOLOL 78 67 22 8
SERTRALINE HCL 77 66 23 25
METOPROLOL TARTRATE 77 71 23 14
ALENDRONATE SODIUM 75 75 25 21
NORTRIPTYLINE HCL 74 74 26 101
TRAZODONE HCL 72 66 27 23
BYSTOLIC 69 67 28 106
AMITRIPTYLINE HCL 68 60 R 29 54
OXYCODONE-ACETAMINOPHEN 67 62 S2 30 49
CHLORTHALIDONE 67 61 30 89
DONEPEZIL HCL 64 64 32 33
ZOLPIDEM TARTRATE 63 58 33 22
RISPERIDONE 56 56 34 83
METFORMIN HCL ER 55 26 35 67
BUPROPION HCL SR 50 48 36 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.